L7 - channelopathies Flashcards

1
Q

define channelopathy

A

dysfucntion in io channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what can cause channelopathies

A

genetics
antibodies
toxins
channels themselves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what can cause genetic mutations in channels

A
radiation (UV, X-rays) 
viruses 
chemicals and toxins 
germ line (errors in DNA replication) 
Somatic (errors in DNA replication)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is a point mutation

A

mutation where one nucleotide in the codon is replaced by another

may or may not change the AA (silent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is a nonsense mutation

A

a point mutation that results in STOP codon being encoded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

when is a point mutation likely to / not likely to be silent?

A

if the mutation occurs in the last nucleotide its possible it may be silent.
if it occurs in the first 2 it is more likely to change the AA thats encoded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is a frameshift mutation

A

insertion or deletion of a nucleotide in the sequence which changes all downstream codons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

define autosomal dominant disease

A

disease expressed in heterozygote, only one allele needed for disease to present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

define autosomal recessive disease

A

disease only expressed in homozygote - two alleles needed

heterozygotes are carriers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

define dominant negative disease

A

where the mutant protein disrupts the function of the normal protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

define haploinsufficiency

A

both genes ( so each allele) are required for full function

for most cases we only require the genes from one allele for full fucntion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

where does the mutation in Hyperekplexia occur

A

the gene encoding glycine receptor

nAChR like receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

symptoms of Hyperekplexia (stiff baby syndrome)

A

muscle spasm in response to unexpected stimuli
-> become rigid and fall over

increased muscle tone as infant (hypertonic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

describe the genetics of hyperekplexia

dom/res, linkage

A
  • autosomal dominant

- genetic linkage on chromosome 5q32 (same place as the glycine receptor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe the mutation and where it occurs in hyperekplexia

what does it result in regarding to the channel activity

A

R271Q in GLRA1
this means point mutation at residue 271 - arginine to glutamine in the glycine receptor, alpha 1 subunit gene

the mutation occurs on TMD2 which is involved in the pore of the channel -> causes channel to lose its ability to respond to glycine, less Cl flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how does the change in channel activity (in hyperekplexia) lead to the symptoms observed in the disease

A

usually in the spinal cord there is glycinergic inhibition of ACh release (from motor neurones to skeletal muscle) via ACh acting on renshaw cells to release glycine (negative feedback)

however in hyperekplexia the glycine receptor no longer responds efficiently to this glycine released, so there is less inhibition and more ACh released to muscles

17
Q

what channel is affected in Generalised Epilepsy with Febrile Seizures (GEFS)

A

voltage gated Na channel

18
Q

symptoms of GEFS

A

convulsions
fever
could result in generalised epilepsy in later life
childhood disease usually resolves with age

19
Q

describe the genetics of GEFS

dom/res, linkage

A

autosomal dominant

linkage chromosome 19q13.1
same place as SCN1B ( sodium channel Beta 1 subunit gene)

20
Q

which is the long and which is the short arm of the chromosome ?

A

P -> short
q -> long

(how to remember: tail of q goes down, it is the bottom long section of the chromosome)

21
Q

describe the mutation in GEFS

A

point mutation C121W (cysteine at 121 replaced by tyrptophan)

22
Q

what is the normal function of the B subunit of the VG Na channel and how does the mutation in GEFS affect this

A

the B subunit has no role in the pore or voltage sensing but can sometimes bind to the (very long) alpha subunit regulating its function

the mutation and loss of cysteine means a disulfide bond cant form in the mutated version where it normally would in the wild type protein

leads to slower inactivation of the channel, so increased Na entry and longer lasting depolarisation (hyperexcitability

23
Q

what channel is affected in Benign Familial Neonatal Seizures (BFNS)

A

ligand gated K channel

24
Q

symptoms of BFNS

A
  • recurrent seizures in early life#
  • starts within first 3 days and resolves within 3 months
  • increased epilepsy in later life
25
Q

describe the genetics of BFNS

location of mutation etc

A

linkage to 20q13.3 (same place as KCNQ2) a gene for K channel

frameshift mutation that leads to ~300AA deletion

leads to haploinsufficiency (one gene isnt sufficient - too few channels)

26
Q

where are KCNQ2 channels found and what is their usual function?

A

nodes of ranvier
axon hillock

they are involved in controlling the M current (amount of recurring APs generated - like refractory period)

27
Q

how does the mutation in BFNS alter aactivity of the channel

A

the mutation isnt in the pore or voltage sensor

the deletion occurs on the C terminal resulting in a non functional protein - not enough K channels expressed

causes repeated AP firing (seizures)

28
Q

what might explain why childhood channelopathies (BFNS and GEFS) resolve on their own?

A

by the body altering expression of the mutated subunit type ( there are several types of each a and B subunit, one of the others may not be mutated)

29
Q

gene therapy could be an option in channelopathies, what are its limitations

A

have to consider:

  • how to get gene into cell
  • how to get gene into correct cell
  • how to insert a gene without disrupting other genes in the genome
  • how is it ensured that the gene is under normal cellular controls